Related Experiment Video
Updated: Aug 22, 2026
Model of Ischemia and Reperfusion Injury in Rabbits
Published on: November 3, 2023
Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling
Xi-Ming Yang1, J Bradley Proctor, Lin Cui
1Department of Physiology, University of South Alabama, College of Medicine, Mobile 36688, USA.
Objectives:
An in situ model was used to test whether and how multiple occlusions at reperfusion can protect rabbit myocardium.
Background:
Recently it was demonstrated that postconditioning in dogs salvaged ischemic myocardium.
Methods:
Control hearts underwent 30-min regional ischemia/3-h reperfusion, whereas in experimental hearts four postconditioning cycles of 30-s occlusion/30-s reperfusion starting 30 s after release of the index coronary occlusion were added in the presence or absence of various cell signaling antagonists.
Results:
Postconditioning decreased infarction from 35.4 +/- 2.7% of the risk zone in control hearts to 19.8 +/- 1.8% (p < 0.05). Six cycles did not result in greater protection. If postconditioning cycles were begun after 10 min of reperfusion, protection was no longer evident. Either the non-selective K(ATP) channel closer glibenclamide or the putatively selective mitochondrial K(ATP) channel antagonist 5-hydroxydecanoate administered 5 min before reperfusion blocked the protection afforded by postconditioning, indicating involvement of the mitochondrial K(ATP) channel. PD98059, a mitogen-activated protein/extracellular-signal regulated kinase (MEK) 1/2 and therefore extracellular-signal regulated kinase (ERK) inhibitor, and N(omega)-nitro-L-arginine methyl ester, an antagonist of nitric oxide synthase, infused shortly before reperfusion also aborted the protection afforded by postconditioning. Combined ischemic postconditioning and preconditioning resulted in significantly greater protection than either alone.
Conclusions:
Multiple, short, regional coronary occlusions immediately after prolonged myocardial ischemia are an effective cardioprotective intervention in the rabbit, and the mechanism of protection involves activation of ERK, production of nitric oxide, and opening of mitochondrial K(ATP) channels. These observations suggest that a similar approach could be applied in the cardiac catheterization laboratory to protect reperfused myocardium after primary angioplasty in patients with acute myocardial infarction.
Insights
Short coronary occlusions after ischemia effectively protect rabbit heart muscle. This cardioprotective strategy involves specific cell signaling pathways and could be used in cardiac catheterization to treat heart attacks.
Area of Science:
- Cardiovascular Research
- Myocardial Ischemia and Reperfusion Injury
- Cell Signaling in Cardioprotection
Background:
- Postconditioning has shown cardioprotective effects in canine models.
- Understanding the mechanisms of postconditioning is crucial for clinical application.
Purpose of the Study:
- To investigate the efficacy of multiple, short occlusions at reperfusion (postconditioning) in protecting rabbit myocardium.
- To elucidate the cellular signaling pathways involved in this cardioprotective effect.
Main Methods:
- An in situ rabbit heart model was used.
- Hearts underwent 30-minute ischemia followed by 3-hour reperfusion.
- Experimental hearts received postconditioning cycles (30-s occlusion/30-s reperfusion) immediately after ischemia, with or without signaling antagonists.
Main Results:
- Postconditioning significantly reduced myocardial infarction size by nearly half compared to controls.
- Involvement of mitochondrial ATP-sensitive potassium (KATP) channels, extracellular signal-regulated kinase (ERK) pathway, and nitric oxide synthase was demonstrated.
- Combined ischemic postconditioning and preconditioning provided enhanced cardioprotection.
Conclusions:
- Immediate postconditioning is an effective cardioprotective intervention in rabbits.
- The mechanism involves mitochondrial KATP channels, ERK, and nitric oxide.
- This approach holds potential for clinical use in patients with acute myocardial infarction undergoing primary angioplasty.
